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ABSTRACT 
This study addresses an important clinical issue by identifying potential candidates of 
VEGF signaling through the Flk-1 receptor that trigger cardioprotective signals under 
ischemic stress. Isolated working mouse hearts of both wild type and Flk-1+/- were 
subjected to global ischemia (I) for 30 min followed by 2 h of reperfusion (R). Flk-1+/- 
myocardium displayed almost 50% reduction in Flk-1 mRNA as examined by 
quantitative real-time RT-PCR at the baseline level. Flk-1+/- mouse hearts displayed 
reduction in left ventricular functional recovery throughout reperfusion (dp/dt 605 vs 
884), after 2 hrs (P<0.05). Coronary (1.9 vs 2.4 ml) and aortic flow (0.16 vs 1.2) were 
reduced in Flk-1+/- after 2 hrs of reperfusion. In addition increased infarct size (38.4 % vs. 
28.41 %, P<0.05) and apoptotic cardiomyocytes (495 vs 213) were observed in Flk-1+/- 
KO mice. We also examined whether ischemic preconditioning (PC), a novel method to 
induce cardioprotection against ischemia reperfusion injury, through stimulating the 
VEGF signaling pathway might function in Flk-1+/-mice. We found that knocking down 
Flk-1 resulted in significant reduction in the cardioprotective effect by PC compared to 
WT. Affymetrix gene chip analysis demonstrated down regulation of important genes 
after IR and PCIR in Flk-1+/- mice compared to WT. To get insight into the underlying 
molecular pathways involved in ischemic preconditioning we determined the distinct and 
overlapping biological processes using Ingenuity pathway analysis tool. Independent 
evidence at the mRNA level supporting the Affymetrix results were validated using real-
time RT-PCR for selected downregulated genes, which are thought to play important 
roles in cardioprotection after ischemic insults. In summary our data indicated first time 
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that ischemic preconditioning modifies genomic responses in heterozygous VEGFR-
2/Flk-1 knockout mice and abolishes its cardioprotective effect on ischemic myocardium. 
Key words: Ischemia, Reperfusion, Flk-1, myocardium, Affymetrix gene chip, Gene 
expressions 
 
 
 4
Introduction 
Angiogenesis offers enormous potential for therapeutic intervention of many human 
disorders. Many angiogenesis - related factors are involved in the development of vessels 
during vasculogenesis, as well as in the induction of new vessels in response to 
physiological or pathological stimuli [1]. Angiogenesis and vasculogenesis are regulated 
predominantly by several different growth factors and their associated receptor tyrosine 
kinases (RTKs) [2]. Foremost among these are the vascular endothelial growth factor 
(VEGF) family and its receptors which are essential regulators of angiogenesis and 
vascular permeability [3]. The central role of vascular endothelial growth factor in 
angiogenesis in health and disease makes it attractive both as a therapeutic target for anti-
angiogenic drugs in pathological conditions such as cancer and as a pro-angiogenic 
cytokine for the treatment of ischemic heart disease. VEGF binds to two receptor protein 
tyrosine kinases, VEGFR1 (Flt-1) and VEGFR2 (Flk-1/KDR), but most of the biological 
functions of VEGF are mediated via Flk-1 [4]. We demonstrated previously that ischemic 
preconditioning (PC) induced angiogenesis in the infarcted myocardium and resulted in 
upregulation of several transcription factors (STAT3, Pax-5, NFκB, TFIID, SP1 etc). In 
addition, PC reduced VEGF-mediated vascular permeability by inhibition of c-Src in the 
ischemic preconditioned group, thereby reducing ischemic injury in rat myocardial 
infarction model [5]. However, the mechanism by which activation of VEGFRs elicits 
these cellular events is not fully understood. Recently attention has been directed toward 
studies of VEGF expression and its function in myocardial ischemia/hypoxia [6-8] and 
relatively little is known regarding the mechanism of its receptors, Flk-1 and Flt-1. VEGF 
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is the only known ligand for Flk-1, whereas Flt-1 is able to bind placental growth factor 
in addition to VEGF.  
Few embryological studies have demonstrated abundance of Flk-1 in human lung tissues, 
whereas Flt-1 was abundant in heart, lung and kidneys [9]. Several investigations 
demonstrated functional difference between Flk-1 and Flt-1 in endothelial cells. In the 
developing human heart, both receptors were expressed in the myocardial capillaries, and 
were known to stimulate intracellular calcium flux and VEGF stimulation. Genetically 
manipulated Flk-1 knockout (homozygous) studies demonstrated early embryonic death 
due to inhibition of vasculogenesis, whereas in another study homozygous Flt-1 
disruption caused failure to assemble normal vascular channels [10]. Another important 
observation showed that Flt-1 was expressed in the endothelium of both large and small 
vessels, whereas Flk-1 expression was restricted only to small vessels [11]. Recent 
studies demonstrated the myocardial distribution pattern of Flk-1 and Flt-1 after rats were 
exposed to whole body hypoxia followed by 24 hours of reoxygenation. Intense staining 
was observed along the capillaries in addition to the coronary arteries [7]. We also 
documented that intensity of staining for both receptors increased significantly in the 
hypoxia/reoxygenation group compared to normoxic control. We also documented 
significant improvement in myocardial function with increased capillary and arteriolar 
density after induction of survival factors VEGF, Bcl-2 and survivin in the chronic rat 
myocardial infarction model subjected to ischemic preconditioning [5]. 
One of our recent studies indicated reduced beneficial effects of PC in Flt-1 heterozygous 
knockout mice compared to wild type. This observation may be due to down regulation 
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of several important genes (obtained by DNA microarray analysis) such as oncogene 1 
(Gro1), heat shock proteins, I Kappa B Kinase β (IKKβ), colony stimulating factor (CSF-
1) and annexin 7, suggesting the importance of VEGF /Flt-1 receptor signaling during 
ischemic preconditioning [12]. To gain a better understanding of the VEGF signaling 
through its other homologous membrane-spanning high affinity tyrosine kinase receptor, 
we performed microarray analysis (Affymetrix Gene Chip Analysis) on Flk-1+/- KO mice 
subjected to I/R and PCIR protocols.  
The results obtained from this investigation not only defined a high number of up and 
down regulated known and unknown genes in IR and PCIR when comparing wild type 
(WT) and KO, but also provided functional network information. We observed many 
differentially expressed genes after IR (115) and PCIR (448) comparison between KO 
and WT mice. Several differentially regulated genes related to cardiovascular 
development and function, cell-cell signaling and interaction were identified. Therefore, 
the data obtained from our Flk-1+/- study should serve as a basis for designing future 
hypothesis driven signaling projects leading to a thorough mechanistic understanding of 
cardioprotection through VEGF signaling.                                                      
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EXPERIMENTAL PROCEDURES 
Experimental animals 
All animals received care in compliance with the principles of laboratory animal care 
formulated by the National Society for Medical Research and Guide for the Care and Use 
of Laboratory Animals published by the National Institutes of Health (NIH). The 
heterozygous Flk-1 KO (Strain name: B6.129-Kdrtm1Jrt/J) mice were purchased from 
Jackson Laboratory (Bar Harbor, Maine, USA).   Restriction maps of the mouse Flk-1  
genomic fragment, targeting construct, and  the structure of the targeted Flk-1 allele is  as  
described [6].  
Experimental protocol 
Wild type (WT) and Flk-1+/– knock out (KO) mice (male) were randomized into four 
groups. For Group I (WTIR), after 10-min stabilization, hearts were perfused for 40 min, 
followed by exposure to zero-flow normothermic global ischemia for 30 min followed by 
120 min of reperfusion (I/R). For Group II (WTPCIR), after stabilization, hearts were 
subjected to four episodes of 4-min global ischemia followed by 6-min reperfusion before 
I/R. For Group III (KOIR), hearts were perfused for 40 min before I/R, and for Group IV 
(KOPCIR), hearts were subjected to the same protocol as WTPCIR.  
Working Heart preparation 
Mice (25-34g) were anesthetized with sodium pentobarbital (150-200 mg/kg body weight 
IP injection, Abbott Laboratories) followed by heparin (500 U/kg bw IP injection, Elkins-
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Sinn Inc) injection. The heart was excised after ensuring sufficient depth of anesthesia 
and immediately immersed in ice cold (4°C) perfusion buffer. The aorta and pulmonary 
vein was cannulated followed by retrograde perfusion in the Langendorff mode through 
the aortic cannula was initiated at a perfusion pressure of 60 mm Hg. The perfusion 
buffer was a modified Krebs-Henseleit Bicarbonate buffer [KHB: composed of (in 
mmol/L) 118 NaCl, 4.7 KCl, 1.2 MgSO4, 25 NaHCO3, 10 glucose, and 1.7 CaCl2, gassed 
with 95% O2:5% CO2, filtered through a 5-µm filter to remove any particulate 
contaminants, pH 7.4] which was maintained at a constant temperature of 37°C and 
gassed continuously for the entire duration of the experiment [13]. After 10 minutes of 
retrograde perfusion, the heart was switched to antegrade perfusion mode where KHB 
buffer entered the cannulated left atrium at a pressure equivalent to 10 cm of water, and 
passed to the left ventricle from which it was spontaneously ejected through the aortic 
cannula. Control measurements of heart rate, coronary flow, aortic flow, left ventricular 
developed pressure, and its first derivative dp/dtmax were monitored, analyzed, and 
recorded in real time using the Digitized data acquisition and analysis system (Micromed, 
Louisville, KY). The stabilization procedure in WTPCIR and KOPCIR groups was 
followed by 4 short cycles of 4 mins ischemia and 6 mins of reperfusion in the 
preconditioning group. The ischemia reperfusion groups (WTIR & KOIR) underwent a 
time matched perfusion. After this period, the hearts in all groups were subjected to 
30 min ischemia. Before the initiation of 2 h reperfusion, the heart was perfused in 
retrograde mode to avoid the development of high incidence ventricular fibrillation. The 
measurements of the cardiac functions were measured out at  30, 60, 90 and 120 min of 
the 2 h reperfusion period.  
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Infarct size 
Infarct size (n=6/group) was measured as previously described [12, 13]. After reperfusion, 
hearts were immediately perfused with 1% (w/v) triphenyltetrazolium chloride. Hearts 
were excised and stored at -70°C. Sections of frozen hearts were fixed in 10% (v/v) 
formalin, placed between two coverslips, and digitally imaged with the use of an Epson 
scanner. To quantitate the areas of interest in pixels, Scion Image (Beta 4.03 for 
windows) analyzing software was used.  
Determination of cardiomyocyte apoptosis 
Formaldehyde-fixed heart tissue sections were embedded in paraffin, cut into transverse 
sections (4 µm thick), and deparaffinized with a graded series of histoclear and ethanol 
solutions. Immunohistochemical detection of apoptotic cells was carried out using a 
TUNEL reaction using In Situ Cell Death Detection Kit, Fluorescein as per the 
manufacturer’s instructions (Roche Diagnostics, Mannheim, Germany).  The sections (n 
= 4) were washed 3X in PBS, blocked with 10% normal goat serum in 1% BSA (w/v) in 
PBS and incubated with anti-α-sarcomeric actin (Sigma, St Louis, MO, USA) followed 
by staining with TRITC-conjugated rabbit anti-mouse IgG (1:200 dilution, Sigma, St 
Louis, MO, USA). After incubation, sections were rinsed thrice in PBS and mounted with 
Vectashield mounting medium (Vector, Burlingame, CA).  Observed images were 
captured using a confocal laser Zeiss LSM 410 microscope.  For quantitation, the number 
of TUNEL-positive cardiomyocytes was counted in 100 high power fields (HPF) [13].  
Microarray Analysis 
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This project was conducted in collaboration with the Cancer Genomics Core facility in 
the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. The 
study was performed with Affymetrix Gene Chip Mouse Genome 430 2.0 array 
(Affymetrix, Santa Clara, CA). Mouse Genome 430 2.0 array is a single array that 
contains over 45,000 probe sets representing approximately 34,000 known mouse genes. 
After completion of the protocols, left ventricular tissue was quickly frozen in liquid 
nitrogen and stored at -80°C. Frozen left ventricles (n=6/group) were homogenized and 
DNA-free total RNA was isolated with RNeasy micro kit (Qiagen, Valencia, CA), 
according to the manufacturer’s instructions. DNase-treated RNA was ethanol 
precipitated and quantified on a NanoDrop ND-1000 spectrophotometer, followed by 
RNA quality assessment by analysis on an Agilent 2100 bioanalyzer (Agilent, Palo Alto, 
California). First-strand cDNA was synthesized using Oligo dT and Superscript II RT 
(Invitrogen, Grand Island, NY). Alternatively, cDNA was prepared using OVATION 
RNA Amplification System (NuGen Technologies, Inc., San Carlos, CA). cDNA 
amplification products were fragmented and chemically-labeled with biotin to generate 
biotinylated cDNA targets. Each Affymetrix gene chip for mouse genome 430 2.0 were 
hybridized with fragmented and biotin-labeled target (2.5 μg) in 200 μl of hybridization 
cocktail.  Target denaturation was performed at 99°C for 2 minutes, followed by 
hybridization for 18 hours. Arrays then were washed and stained using Genechip Fluidic 
Station 450, and hybridization signals were amplified using antibody amplification with 
goat IgG (Sigma-Aldrich) and anti-streptavidin biotinylated antibody (Vector 
Laboratories, Burlingame, CA). Chips were scanned on a Affymetrix Gene Chip Scanner 
3000, using GeneChip Operating Software (GCOS) version 3.0. Background correction 
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and normalization were done using Robust Multichip Average (RMA) with Genespring 
V 7.3.1 software (Silicon Genetics, Redwood City, CA). Volcano plots were used to 
identify differentially expressed genes using the parametric testing assuming variances 
are equal (filters based on the results of a Student's two-sample t-test for two groups or a 
one-way analysis of variance (ANOVA) for multiple groups) and no multiple testing 
correction. Two different comparisons were done (WTIR vs KOIR and WTPCIR vs 
KOPCIR). The differentially expressed gene list was loaded into IPA 5.0 software 
(www.ingenuity.com) to perform biological network and functional analyses.  
Quantitative real-time RT-PCR 
Reverse transcription (RT) was performed with 1 μg total RNA isolated from left 
ventricular tissue (n=6/group)  of WT and Flk-1+/– heterozygous KO mice subjected to 
I/R with or without PC. Real-time RT-PCR analysis was done with 10ng of RT product 
using the iCycler iQ detection system (Biorad, Hercules, CA) employing Syber Green I 
fluorescence employing β-actin as reference control [12, 13]. Primer sequences used for 
real-time RT-PCR are given in Table 1 (Supplemental file)  
Statistical analysis 
The values for myocardial hemodynamic parameters, infarct size, apoptosis and 
quantitative real time PCR were all expressed as the mean ± standard deviation (± SD). 
Differences between groups were tested for statistical significance by one-way analysis of 
variance (ANOVA) followed by a Bonferroni correction to test for differences between the 
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mean values of all groups with the help of statistical tool (SPSS 15.0). The results were 
considered significant if p < 0.05. 
 
RESULTS 
Characterization of Flk-1 heterozygous KO mice 
Almost 50% reduction in Flk-1 mRNA was found in hearts from heterozyogous Flt-1 KO 
mice (Fig. 1A, B) assessed by both RT-PCR and real-time RT-PCR. Moreover, Flk-1 
mRNA expression is significantly inhibited in the KOPCIR compared to the WTPCIR 
myocardium. As expected, expression of Flt-1 and VEGF mRNA are not affected in Flk-
1+/– mice before or after I/R (Fig. 1A, B); however, after PC both Flt-1 and VEGF mRNA 
expression in KOPCIR and WTPCIR were increased compared to  I/R. 
Effect of Flk-1 heterozygosity on the recovery of ventricular function after ischemia 
reperfusion: There was no significant difference in baseline function among the four 
groups. Throughout the study, the heart rate and coronary flow were not different between 
the two groups (data not shown). The functional values of each parameter such as LVDP, 
dp/dtmax and aortic flow were significantly decreased in all groups after 30 min of global 
ischemia, as expected, compared to their respective baseline values. Post ischemic 
myocardial function was disrupted in the Flk-1+/- mice significantly as evidenced by the 
significant decrease in left ventricular developed pressure (LVDP), dp/dtmax and aortic flow 
(AF) compared to wild type control.  A significant decrease in LVDP (Fig. 2A) was 
observed throughout the reperfusion period (except at 30’R). Values after 120 minutes of 
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reperfusion for LVDP in KOIR (49.8±1.2) and KOPCIR (54.4±2.6) decreased compared to 
WTIR (56.8±1.1) and WTPCIR (65±3). A Significant decrease in dp/dtmax (Fig. 2B) also 
was obtained throughout the reperfusion time after 120 minutes of reperfusion in both 
KOIR (605 ±13) and KOPCIR (818 ±55) significantly reduced as compared to the WTIR 
(884±51) and WTPCIR (1267±51), respectively. Similarly, aortic flow (Fig. 2C) was 
significantly decreased after 120 minutes of reperfusion in both KOIR (0.16 ±0.1) and 
KOPCIR (1.3 ±0.5) compared to WTIR (1.2 ±0.18) and WTPCIR (4.3±0.72).  
 Effect of Flk-1 inhibition on Myocardial Infarct Size    
Infarct size expressed as percent infarction relative to total area at risk was noticeably 
increased in Flk-1+/- mouse hearts compared to controls (Fig 3A). Transversal cross 
sections from Flk-1+/- hearts, which underwent ischemia reperfusion (38.4 %) and 
ischemic preconditioning (27.8%) indicated significantly larger (P<0.05) infarct size 
compared to WTIR (28.41%) and WTPCIR (19.4%) heart sections.   
Effect of Flk-1 inhibition on cardiomyocyte apoptosis by Tunnel Assay 
Apoptotic cardiomyocytes (Fig. 3B) were detected using TUNEL staining in conjunction 
with staining for α-sarcomeric actin. Apoptotic cardiomyocytes were significantly 
increased in the KOIR (495) and KOPCIR (335) groups when compared to the WTIR 
(213) and WTPCIR (116) groups (Fig 3C). Hence heterozygosity for Flk-1 increased 
cardiomyocyte cell death due to apoptosis compared to controls. Thus, the extent of 
cardiac injury is much more prominent in Flk-1+/- KO mice when subjected to ischemia 
 14
reperfusion than controls. It is also clear that PC mediated cardioprotection is disrupted in 
the KO compared to controls.  
Gene expression changes in the FLK-KO and WT mice by Affymetrix Microarray 
analysis  
Microarray gene profiling was conducted with RNA isolated from the left ventricles of 
wild type and knock out mice to identify genes involved in ischemic preconditioning 
mediated VEGF signaling. Microarray analysis was performed on RNA isolated from 
each group to identify differentially expressed genes, using the Affymetrix 430 2.0 mouse 
genomic array. Signals were loaded into Gene Spring 7.3.1 software and normalized 
using the Robust Multichip Average (RMA) algorithm (Supplemental Figure 1). The 
differentially expressed genes were further filtered using a Volcano plot (Figure 4).  This 
plot shows two important measures of differential expression in one plot (-Log10(P value) 
vs Log2(Fold change)), allowing decision on which genes are differentially expressed at a 
particular p-value. The gene expression profile of mouse hearts subjected to PCIR and IR 
alone in KO mice was compared to the respective PCIR and IR groups in WT mice,. i.e 
(WTIR vs KOIR and WTPCIR vs KOPCIR). The average expression level for each gene 
was calculated from biological duplicates. Using this Volcano plot at a value P<0.1, 
showed 628 differentially expressed probe sets in KOIR vs WTIR, (Figure 4A) and 1394 
differentially expressed probe sets in KOPCIR vs WTPCIR (Figure 4B). The gene list 
was reduced to 448 (KOPCIR VS WT PCIR) and 115 (KOIR vs WTIR) differential 
expressed genes after applying a cut off intensity 100. A summary of the total number of 
differentially expressed genes based on a P value <0.1 as shown (Tables 2A and 2B). 
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With the goal of discovering specific patterns, hierarchical clustering (Pearson 
correlation) was applied to the expression profiles of 555 genes (total number of 
differentially regulated genes). These data are represented by a gene tree (Figure 5) in 
which genes of most similar expression patterns are closest to one another. A gene tree or 
heat map is a graphical means of comparing many genes and samples at one time where 
each gene and sample is represented by a row and column, respectively. Gene expression 
(Normalized expression) levels are depicted as color variation from red (high expression) 
to blue (low expression).  
A partial list of down regulated transcripts in WTIR vs KOIR comparison (Table 3) and 
in WTPCIR vs KOPCIR (Table 4) is shown. Important genes down regulated in the KO 
as compared to WT mice include KDR, Syndecan 1 and VCAM-1 which plays an 
important role in the cardiovascular function.  
Venn diagram in Figure 6A compares differentially expressed genes in between the two 
different comparisons, which showed 45 common genes were differentially regulated. 
Further classification of the 45 genes according to biological function (Figure 6B) was 
determined from the Netaffx gene ontology tool, Affymetrix analysis shows that 11 genes 
are involved in the catalytic activity, 25 genes in the binding activity and 5 in signal 
transduction activity. A pie chart shows commonly regulated functions (Netaffx gene 
ontology tool, Affymetrix) for the different comparisons (Figure 6).  
Biological Network and Functional Analysis: 
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Inorder to further refine the functional properties of the genes down regulated, the total 
down regulated genes in both the comparison (1156 genes) was loaded in the IPA tool for 
the network, functional and pathway analysis. Ingenuity Pathway Analysis (IPA) 
converts a list of genes (with or without accompanying expression information) into a set 
of relevant networks based on the Ingenuity Pathways Knowledge Base (IPKB). Total 
down regulated genes (1156 transcripts) in both comparisons were selected and used for 
network generation and functional analysis. Affymetrix probe ID and P-value were 
loaded into the IPA software. A core analysis is performed for the list of genes in 
individual groups, which was followed by comparison analysis (WTIR vs KOIR & 
WTPCIR vs KOPCIR). The genes were categorized based upon molecular function in the 
IPA software. The identified genes were also mapped to genetic networks in the IPA 
database and ranked by score. The score reflects the probability that a collection of genes 
equals to or greater than the number in a network could be achieved by chance alone. A 
score of more than 10 was used as a cut-off for identifying gene networks. The list of 
networks generated (Table 5A and 5B) and important networks related to cardiovascular 
function in each comparison is given (Figure 7A and B). Network analysis revealed two 
important genetic networks related with the cardiovascular development, which is shown 
in the figure 7A (WTIR vs KOIR) and 7B (WTPCIR vs KOPCIR). Two networks had a 
high score of 42 and 26 with 22 and 16 focus genes, respectively. Several important 
genes such as AKT, AP1, FGF1, HIF1A, IL1, MAP3k3, MEK, P38MAPK, VEGF, 
Eif2s3, KDR etc are related in the network. Further functional and pathway classification 
showed, several genes down regulated related to organismal injury and abnormalities, 
cardiovascular system development and functions, free radical scavenging, cellular 
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growth and proliferation, skeletal and muscle disorder in both the comparisons. Table 6 
and 7 shows the list of functions with respect to the p value and related number of genes 
in WTIR vs. KOIR and WTPCIR vs. KOPCIR comparison. 
Validation of differentially expressed genes by realtime RT-PCR. 
Real-time RT-PCR analysis was performed to confirm the relative expression patterns of 
randomly chosen down regulated genes in both comparisons. The four experimental 
groups (WTIR, KOIR, WTPCIR and KOPCIR) were assessed for each transcript. This 
approach led to successful verification of nine transcripts involved in VEGF-mediated 
cardioprotection through Flk-1 signaling during ischemic preconditioning and include 
VCAM, HIF-1A and Mitogen-Activated Protein Kinase Kinase 7 (Figure 8). The mRNA 
levels of VCAM, HIF-1A, Mitogen-Activated Protein Kinase Kinase 7 along with other 
genes increased in PC groups as compared with the IR groups in both KO and WT mice. 
However, the levels were significantly decreased in KO mice. Real time RT-PCR 
analysis revealed results consistent with the microarray data, thus demonstrating the 
accuracy of the array approach. 
Discussion 
This study explores for the first time how ischemic preconditioning mediated 
cardioprotection modifies genomic responses significantly in Flk-1 heterozygous receptor 
knock out mice and disrupts PC mediated cardioprotection. Expression of VEGF receptor 
tyrosine kinases such as Flk-1 and Flt-1 in endothelial cells has made it difficult to 
document individual contributions of each receptor to VEGF signaling. This study shows 
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that ischemia/reperfusion and / or PC modifies genomic responses in Flk-1+/-KO 
myocardium compared to WT, specifically, modifing expression of genes responsible for 
myocardial response to ubiquitination, angiogenesis and survival, etc. that are obviously 
important for cardio protection.  In the current study, we used genetically manipulated 
heterozygous Flk-1 (50% down regulated) knockout mice because homozygous KO mice 
are not viable due to early embryonic death caused by inhibition of vasculogenesis [10]. 
As assessed by RT-PCR and real-time RT-PCR, VEGF and Flt-1 mRNA 
expression in KO mice, compared to WT mice, are not affected at the baseline level by 
disruption of the Flk-1 gene. However, after preconditioning, both VEGF and Flt-1 
mRNAs are significantly up-regulated in WTPCIR and KOPCIR compared to their 
respective IR groups. On the other hand, as expected Flk-1 mRNA was down regulated 
(50%) at the baseline level as well as in the KOPCIR group. These observations indicate 
that disruption of Flk-1 gene does not affect PC-mediated up regulation of VEGF and Flt-
1 mRNA. Again, functional recovery after PC deteriorates in Flk-1+/- compared to wild 
type mice. Infarct size is also found to be greater in the KOPCIR (27.8%) than in the 
WTPCIR (19.4%) group; and therefore, PC-mediated cardio protection is diminished 
significantly even though these are heterozygous knockout mice with 50% of Flk-1 
receptors still available for VEGF-mediated signaling.  
In this study, we have confirmed that PC-induced VEGF signaling is disrupted by 
knocking down Flk-1, and is characterized by a decrease in hemodynamics, an increase 
in infarct size and apoptosis. Several high-throughput technologies have been used to 
investigate the effect of ischemic preconditioning mediated myocardial changes [14, 15]; 
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but, to our knowledge, this is the first microarray study of global gene expression in Flk-
1+/- mice using high density oligonucleotide microarrays. Left ventricular RNA samples 
from six mice in each group were analyzed for differential expression by hybridizing 
with Affymetrix 430 2.0 Mouse arrays.  Our data uncovered several pathways induced by 
VEGF signaling through Flk-1 and provide a frame work for comparing whole heart gene 
expression changes associated with ischemic preconditioning.  
 Gene chip data analysis with the help of Genespring software analysis revealed 
448 genes and 115 genes differentially expressed  in WTIPCIR vs KOPCIR and WTIR 
and KOPCIR comparison which showed the involvement of several genes related with 
ischemic preconditioning mediated VEGF-Flk-1 signaling. Identification of the 
differentially expressed genes and cluster analysis [16] of these genes are the important 
initial steps, but further analysis of these genes by IPA software for networks/functional  
analysis allowed us to look into more informative and convincing evidence of changed 
biological processes due to ischemic preconditioning. Pathway analysis showed several 
genes such as presenelin -1, AKT, AP1, FGF1, HIF1A, IL1, MAP3k3, MEK, P38MAPK, 
VEGF, Eif2s3, KDR related to WNT, FGF, PI3 kinase, cardiac β adrenergic, VEGF and 
platelet derived growth factor signaling etc downregulated in the KO mice as compared 
with the WT mice during ischemic preconditioning. Hence the pathway analysis proved 
that knocking down Flk-1 showed disruption of several important signaling mechanisms 
related with myocardial angiogenesis.  
To independently validate array data, 8 downregulated genes related to myocardial 
angiogenesis and cardioprotection were selected randomly followed by qRT-PCR 
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analysis. The genes include syndecan-1, NA+/K+ ATPase transporting, beta 1 polypeptide, 
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide, protein kinase C nu, mitogen 
activated protein kinase kinase 7, vascular cell adhesion molecule 1, hypoxia inducible 
factor-1, alpha subunit and glutathione reductase.  
Syndecan 1 is a cell surface proteoglycan and an integral membrane protein acting as 
receptors for the extracellular matrix. Syndecan 1 has been proven to modulate WNT 
pathway [17], which is important in cell signaling. Na+.K+ ATPase activity in the 
myocardium plays an important role in generating the rapid upstroke of the action 
potential and drives several ion exchange and transport processes crucial for normal 
cellular functions [18].  
In addition, Phosphatidylinositol 3-kinase is found in the down regulated list, and is 
composed of 85-kD and 110-kD subunits. The 85-kD subunit lacks PI3-kinase activity 
and acts as an adaptor, coupling the 110-kD subunit (p110) to activated protein tyrosine 
kinases. Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide has been reported to 
play an important role in VEGF mediated angiogenesis [19].  Homozygous knockout for 
this gene leads to embryonic lethality. Hetrozygous mice were viable and fertile [20], but 
showed severely blunted signaling via IRS proteins, which is a key mediator of insulin, 
IGF1 and leptin action. Evidence also suggested [21]a critical role for p110-alpha in 
growth factor and metabolic signaling. Our study shows that p110 alpha plays an 
important role in several signaling pathways, including myocardial angiogenesis.  
Another intriguing gene on this list was Protein Kinase Cμ. Protein kinase D 
(PKD)/protein kinase Cµ [22,23] and two recently identified serine protein kinase’s 
 21
termed PKD2 and PKC /PKD3, which are similar in overall structure and primary amino 
acid sequence to PKD [23-25] and constitute a new protein kinase subfamily separate 
from the previously identified PKCs..  
Interestingly, two important genes (VCAM 1 and HIF-α) were identified as 
downregulated. HIF-1 (hypoxia-indicible factor-1) is a heterodimer consisting of HIF-1α 
and HIF-1β subunits.  The regulation of HIF-1 activity is mainly through the HIF-1 α 
subunit.  Translocation of HIF-1 α to the nucleus and heterodimerization of the alpha and 
beta subunits demonstrates adaptive responses to ischemia [26] in the myocardium 
promoting angiogenesis by activating target genes such as VEGF, LDH and several other 
genes.  
 VCAM-1 is a member of the immunoglobulin super family of adhesion molecules [27].  
VCAM -1 is expressed in fibroblast-like cells. The extent of the intensity of VCAM-1 
expression correlates the degree of inflammation. The interaction of VCAM-1 and its 
ligands, the integrins may play significant role in angiogenesis. Pathway analysis also 
demonstrated down regulation of Glutathione reductase (GR) which is a homodimeric 
flavoprotein which maintains the cellular thiol redox state by catalyzing the reduction of 
glutathione disulfide (GSSG) to glutathione. Its activity is present in both the cytosol and 
mitochondria [28].  
In conclusion, use of gene chip technology allowed us first time for the identification of 
several target genes downstream of VEGF/Flk-1 signaling in PC myocardium.  Moreover, 
biological network and pathway analysis revealed several other related genes indirectly 
affected due to down regulation of directly affected genes in KO.  Finally, to our 
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knowledge this is the first report in VEGF receptor-2 knockout mice (Flk-1+/-) in which 
several important genes related to cardioprotection and angiogenesis have been 
documented and should help to facilitate the design of effective future therapies.   
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Figure Legends 
Figure 1: RT-PCR and real-time RT-PCR analysis for Flk-1, Flt-1 and VEGF. (A) 
Relative abundance (%) of Flk-1, Flt-1 and VEGF mRNA in wild type and Flk-1+/– 
knockout myocardium (n=6/group) at the baseline level, after ischemia/reperfusion (I/R) 
and after ischemic preconditioning (PCI/R) followed by I/R. (B) Quantitative real-time 
RT-PCR analysis validating RT-PCR data for VEGF, Flt-1 and Flk-1 mRNA. *p < 0.05 
compared with WT ischemia/reperfusion, #p < 0.05 compared with WT preconditioning, 
†p < 0.05 compared with KO ischemia/reperfusion 
Figure 2: Effects of ischemia/reperfusion and preconditioning on left ventricular 
function of wild-type and Flk-1+/− mice. Postischemic ventricular recovery of FlkKO 
and wild-type mouse hearts (n=6/group) is presented. The results ((A) LVDP, (B) 
dp/dtmax and (C) aortic flow are shown in Mean ±  S.D form six animals per group. *p < 
0.05 compared with WT ischemia/reperfusion, #p < 0.05 compared with WT 
preconditioning, †p < 0.05 compared with KO ischemia/reperfusion. WTIR: wild type 
I/R, WTPCIR: preconditioned wild type, KOIR: Flk-1+/– knockout I/R, KOPCIR: 
preconditioned Flk1+/– knockout. 
Figure 3:  Effects of ischemia/reperfusion and preconditioning on infarct size and 
cardiomyocyte apoptosis of wild-type and Flk-1+/− mice.  (A) Infarct size of the hearts 
is expressed as a percentage of the area at risk in mouse myocardium subjected to 30 min 
of ischemia followed by 2 h of reperfusion. Results are expressed as means ± SD of six 
hearts/group. (B &C) TUNEL assay for apoptotic cardiomyocytes cells after 
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ischemia/reperfusion and preconditioning of wild-type and Flk-1+/− mice after ischemia. 
TUNEL assay for apoptotic cells was performed as described under Experimental 
procedures. Representative photographs show immuno histochemical staining of 
extended DNA. Results are expressed as means ± SEM of six hearts/group. *p<0.05 
compared with wild-type ischemia/reperfusion group, #p < 0.05 compared with 
Flk+/−ischemia/reperfusion group, †p < 0.05 compared with wild-type preconditioning 
group. WTIR: wild type I/R, WTPCIR: preconditioned wild type, KOIR: Flk-1+/– 
knockout I/R, KOPCIR: preconditioned Flk1+/– knockout. 
Figure 4: Volcano plot pictures showing the differentially regulated genes in both 
the comparisions.  A) KOIR vs. WTIR, B) KOPCIR vs. WTPCIR.  Volcano plot was 
used as filter to view the differentially expressed genes. A Volcano Plot shows the 
Log2(Fold change) in X-axis against the –Log10(P value) in Y-axis. It shows two 
important measures of differential expression in one plot. Filter genes for a 1.5 fold 
difference and p-value cut-off of 0.1. WTIR: wild type I/R, WTPCIR: preconditioned 
wild type, KOIR: Flk-1+/– knockout I/R, KOPCIR: preconditioned Flk1+/– knockout.  
Figure 5: Hierarchic clustering of differentially expressed genes in wild type and 
FLK-1+/- mice after Ischemia reperfusion and ischemic preconditioning. Data 
filtering by volcano plot identified 555 genes together in both the comparisons (WTIR Vs 
KOIR and WTPCIR vs KOPCIR). Gene expression levels are depicted as color variation 
from red(high expression) to blue (low expression) The color in each cell of the figure 
displays the level of expression for each gene (row) in the myocardium of each group 
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(mean of duplicate valve) (column). WTIR: wild type I/R, WTPCIR: preconditioned wild 
type, KOIR: Flk-1+/– knockout I/R, KOPCIR: preconditioned Flk1+/– knockout. 
Figure 6: A Venn diagram shows the common differentially expressed genes in 
between two comparisons, (KO I/R vs WT I/R and KOPCIR vs WT PCIR). (B). Pie 
chart shows the classification of differentially expressed genes based on biological 
functions (Netaffx gene ontology tool, Affymetrix). The number represents the genes 
associated with a specific function.Note that some genes may have multiple functions and 
be classified in several categories. WTIR: wild type I/R, WTPCIR: preconditioned wild 
type, KOIR: Flk-1+/– knockout I/R, KOPCIR: preconditioned Flk1+/– knockout. 
Figure 7: Functionally related gene network constructed from both the comparisons 
WTIR vs. KOIR (A) and WTPCIR vs. KOPCIR (B) related with cardiovascular system 
with the help of IPA 5.0.Nodes represent genes, with their shape representing the 
functional class of the gene product. All the focus genes are represented by pink and the 
higher intensity red color represent lower P- value WTIR: wild type I/R, WTPCIR: 
preconditioned wild type, KOIR: Flk-1+/– knockout I/R, KOPCIR: preconditioned Flk1+/– 
knockout. 
Figure 8:  Independent validation of down-regulated genes by real-time RT-PCR. 
*p<0.05 compared with wild-type ischemia/reperfusion group, *p<0.05 compared with 
WT ischemia/reperfusion, #p < 0.05 compared with WT preconditioning, †p < 0.05 
compared with KO ischemia/reperfusion. WTIR: wild type I/R, WTPCIR: preconditioned 
wild type, KOIR: Flk-1+/– knockout I/R, KOPCIR: preconditioned Flk1+/– knockout.  
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Table 2A Differential expressed genes in KOIR mice as compared with WTIR 
mice at different statistical 
 criteria using Volcano plot as a filter 
 
Fold 
Change 
P Values Probe sets 100 Cut off Unique genes after 
100 cut off 
2 0.05 79 18 18 
2 0.1 172 34 32 
1.5 005 306 56 56 
1.5 0.1 628 115 114 
 
Table 2B Differential expressed genes in KOPCIR mice as compared with 
WTPCIR mice at different statistical  
criteria using Volcano plot as a filter 
 
Fold 
Change 
P Values Probe sets 100 Cut off Unique genes after 
100 cut off 
2 0.05 195 64 62 
2 0.1 419 143 138 
1.5 005 646 187 180 
1.5 0.1 1394 448 425 
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Table 3. List of selected Downregulated genes in FLKIR vs WTIR 
 
 
Affy ID Gene Symbol Description 
1419697_at CXCL11 chemokine (C-X-C motif) ligand 11 
1437478_s_at EFHD2 EF hand domain containing 2 
1423136_at FGF1 fibroblast growth factor 1 
1424877_a_at ALAD aminolevulinate, delta-, dehydratase 
1434008_at SCN4B sodium channel, type IV, beta 
1417343_at FXYD6 
FXYD domain-containing ion transport 
regulator 6 
1448304_a_at RAB6 RAB6, member RAS oncogene family 
1449379_at KDR kinase insert domain protein receptor 
1452445_at SLC41A2 solute carrier family 41, member 2 
1436576_at A630077B13RIK RIKEN cDNA A630077B13 gene 
1424365_at 1810037I17RIK RIKEN cDNA 1810037I17 gene 
1416124_at CCND2 cyclin D2 (very important) 
1439540_at MARCH2 membrane-associated ring finger (C3HC4) 2 
1451343_at VPS36 vacuolar protein sorting 36 
1450036_at SGK3 serum/glucocorticoid regulated kinase 3 
1436959_x_at NELF nasal embryonic LHRH factor 
1452053_a_at TMEM33 transmembrane protein 33 
1459783_s_at CNO Cappuccino 
1434598_at LARP5 
La ribonucleoprotein domain family, 
member 5 
1448780_at SLC12A2 solute carrier family 12, member 2 
1422464_at MRPL3 mitochondrial ribosomal protein L3 
1415943_at SDC1 syndecan 1 
1434577_at BC052040 cDNA sequence BC052040 
1422492_at CPOX coproporphyrinogen oxidase 
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Table 4. List of selected Downregulated genes in FLKPC vs WTPC 
 
 
Affy ID Gene Symbol Description 
1448183_a_at Hif1a hypoxia inducible factor 1, alpha subunit 
1416123_at Ccnd2 cyclin D2 
1449379_at Kdr kinase insert domain protein receptor 
1437284_at Fzd1 frizzled homolog 1 (Drosophila) 
1415988_at Hdlbp high density lipoprotein (HDL) binding protein 
1433972_at Camta1 calmodulin binding transcription activator 1 
1420491_at Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha 
1455396_at Atp8b1 ATPase, class I, type 8B, member 1 (Atp8b1), mRNA 
1428230_at Prkcn protein kinase C, nu 
1459457_at Camk2d calcium/calmodulin-dependent protein kinase II, delta 
1425354_a_at Aggf1 angiogenic factor with G patch and FHA domains 1 
1421821_at Ldlr low density lipoprotein receptor 
1423144_at Pik3ca phosphatidylinositol 3-kinase, catalytic, alpha polypeptide 
1425512_at Map2k7 mitogen activated protein kinase kinase 7 
1424681_a_at Psma5 proteasome (prosome, macropain) subunit, alpha type 5 
1418453_a_at Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide 
1430500_s_at Mtx2 metaxin 2 
1451090_a_at Eif2s3x eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked 
1436003_at Vcam1 vascular cell adhesion molecule 1 
1460303_at Nr3c1 nuclear receptor subfamily 3, group C, member 1 
1430990_s_at Mrpl44 mitochondrial ribosomal protein L44 
1425993_a_at Hsp110 heat shock protein 110 
1423330_at Ensa endosulfine alpha 
1423456_at Bzw2 basic leucine zipper and W2 domains 2 
1417204_at Kdelr2 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 
1433641_at Smad5 MAD homolog 5 (Drosophila) 
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     Table 5A: Selected Genetic Networks with High scores (>10) in 
WTIR vs.    KOIR comparison 
 
Molecules in network Score 
Focus 
genes Top functions 
Akt,Ap1,BTRC,CAMK2D,CLEC11A,CXCL1,CXC
L11 (includes EG:6373), EIF2S1, FCGR1A, FGF1, 
HIF1A, HOMER1, IL1, IL11, IL1R2, Jnk, 
MAP3K3, Mapk, Mek, P38 MAPK, PI3K, Pkc(s), 
PMCH, PP2A, PPP1R1A, PSCD3, PSCDBP, 
PSMC3IP, PTGFR, RTN4, SIAH1, SLC12A7, 
ULBP2,Vegf,WNK1 
42 22 Cardiovascular System 
Development and Function, Cell-
To-Cell Signaling and Interaction, 
Gene Expression 
amino acids, ARHGDIG, ARHGEF11, B3GALT2, 
CASC3, CD38, CDC6, CDC25C, CENPJ, COG2, 
COG7, CPE, GYS1 (includes EG:2997), HNRPA1, 
HNRPC, hydrogen peroxide, INS1, MAGOH, 
MCF2L, MPO, NXF1, PHGDH, PLK3,POLR2A, 
POU2F1, PPM1D, PTPRO, RBM8A, RCN1, 
RHOA, RHPN2, SYTL4,THOC4,TNF,TNFAIP8 
27 15 Carbohydrate Metabolism, Lipid 
Metabolism, Molecular  Transport 
ARFGEF1,ARHGDIG,ARHGEF11,beta-estradiol, 
CAD,CD200,CD200R1,CDH4,CLCN3,CRSP2,CUB
N,DOK1,EGF,FOXA2,HCRTR2,IGHMBP2,LDLR,
Mmp,MMP2,MYO9B,PDGFB,PKIB,PLCE1,PSCD
3,RHOA,SCARB1,SERPINA1,SETD7,SGK3,SLC9
A3R1,TAF7,TBN,TBP,TRFP,USP6NL 
25 15 Lipid Metabolism, Molecular 
Transport, Small Molecule 
Biochemistry 
AK3L1,ATR,CCNA1,CCNA2,CD9,CDC6,CDC25A
,CDC25B,CDC25C,CDK6,CHEK2,COL18A1,CPO
X,E2F6,E2F1 (includes EG:1869), EGLN1, ERCC3, 
FBXW11, FLI1, GTF2H1, HIF1A,MGA (includes 
EG:23269),MXD4, MYCT1, NDNL2, NRN1, 
PRKDC,RBX1, SREBF1, STARD4, TGFB1, 
TP53,USP7,ZFP161,ZNF22 
24 14 Cell Cycle, Gene Expression, DNA 
Replication, Recombination, and 
Repair 
AHR,CLEC11A,CYP2B6,DLG2,DLG3,DLGAP1,D
NAJC11,FLNB,FOS,GRASP,GRIN1,heparin,HLTF,
IL10,MAGI2,MLLT10,MMP2,MPG,NRP1,PCNX,P
OLR3A,POLR3F,PPARBP,RB1,RBBP9,retinoic 
acid, SE -MA3D, SHANK2, SMARCA4,S MAR -
CB1, SPTBN1, ST6GALNAC4, TCOF1 (includes 
EG:6949), YY1,ZFAND5 
25 15 Organismal Development, Gene 
Expression, Cancer 
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Table 5B: Selected Genetic Networks with High scores (>10) in 
WTPCIR vs. KOPCIR comparison 
 
Molecules in network Score 
Focus 
genes Top functions 
ADRBK2,BTRC,CCND2,Creb,DRD1,DYRK2,FCGR
2B,FLI1,GRIP1,HDC,HIF1A,HIF1AN,HLTF,IL11,Jnk
,Mapk,MAPT,NCAM1, NPR3,P38 MAPK, Pdgf, 
PI3K, Pkc(s), PMCH,PRKG1 (includes EG:5592), 
RUNX -1, Scf, SLC6A3,SP1, TCF12, Tgf beta,  TLR4, 
Vegf,WNT5A,YES1 
45 24 
Cell-To-Cell Signaling and 
Interaction, Cellular Growth and 
Proliferation, Cellular 
Development 
Akt,Ap1,APAF1,CXCL11 (includes EG: 
6373),DUSP6,FLI1, FST,Hsp90,Jnk, LDL R, 
Mapk,NR3C1, P38 MAPK,p70 S6k, Pdgf, PDGFC, 
PEPCK, PI3K, PIK3C3, PIK3CA, PMCH, 
PP1/PP2A,PPARGC1A,PPM1L, PPP1R11, PSCDBP, 
PSMC3IP, RASSF1, Scf,SULF1, TFDP1,Tgf 
beta,TLR3, TRAF3, VCAM1 
40 22 
Endocrine System Development 
and Function, Lipid Metabolism, 
Molecular Transport 
AMOTL1,beta-estradiol, BMX, CD44, CDH11, 
CEBPG, CXCR7,DAG1, EIF2S3, FIGF, GBP2 
(includes EG:14469),GFAP, GPC1, GPRC5A, 
IFNGR2, IL6, IL15, KDR,L-carnitine, LARGE, MVP, 
NFKBIZ, NRP1,PLP1,PPP5C, PRKDC, PSEN1, 
psychosine, RAPGEF5, SDC3, SNX10, ST6GAL1, 
TNF, TNFAIP8,VEGFC 
26 16 
Cellular Movement, 
Cardiovascular System 
Development and Function, 
Organismal Development 
ARCN1,ATM/ATR,BCL10,BRCA1,BRCC3,BRE,CA
SP9,CCND2,CHEK2,DAG1,ELK1,EPOR,GAST,HDC
,HMGN3,IL3,IL1RL1,KLF7,MDC1,PCDH7,PLK3,PT
X3,RAD50,RANBP9,RAPGEF5,RELB,ROBO1,SRP
K2,TNF,TNFAIP3,TNFAIP6,TNFAIP8,TROVE2,USP
11,ZFAND5 
26 16 Cell Death, Cell Cycle, Cancer 
ATR,Caspase,CDH1,CDT1,CEP55,CUL4B,ERCC1,E
TS1,FAM3C,Groucho,HAS2,HNRPA2B1,HRAS,HR
ASLS,IGFBP3,IGSF4(includesEG:23705), JMJD1C, 
MATN4, MLLT4, NOTCH1, P8, PAXIP1, 
PVR,PVRL-  3, RUNX1, SOAT1,  SON, TIMP3, 
TLE1, TP53, TP53BP1, TRIM44, UPP1, UTY, Zn2+ 
24 15 Cell Death,Connective Tissue Disorders,Cancer 
ATXN1,AURKA,CDC7,CEP55,CHGN,DBF4,DDX6 
(includes EG:1656), EP400, GAPDH (includes 
EG:2597), GPS2, GSR,JMJD1C, KIAA1267,MAP4, 
MARK4 (includesEG:57787), MCM2,MCM4, MCM6, 
MCM7,MED6,MGA (includes EG:23269), MLL, 
PPP1R15A (includes EG:23645), PRNP, PVRL3, 
SFRS10, TBL1X, TFDP1, THPO,TNFRSF10A 
24 15 
DNA Replication, 
Recombination, and Repair,Cell 
Cycle,Cell Death 
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(includes EG:8797), TP53, TRIM44, TXNRD1, 
USP7,WDR5 
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Table 6: Gene ontology analysis of the genes affected in WTIR vs. KOIR 
comparison 
 
Relevant Functions P Value No of Molecules 
Organismal Injury and Abnormalities 8.39E-4 - 4.76E-2 10 10 
Cardiovascular System Development and Function 8.39E-4 - 4.47E-2 9 9 
Free Radical Scavenging 7.59E-3 - 7.59E-3 1 1 
Cellular Growth and Proliferation 7.59E-3 - 4.95E-2 23 23 
Hematological System Development and Function 7.59E-3 - 4.95E-2 14 14 
Molecular Transport 7.59E-3 - 4.57E-2 12 12 
Cellular Development 7.59E-3 - 4.47E-2 7 7 
Connective Tissue Development and Function 7.59E-3 - 4.47E-2 6 6 
Drug Metabolism 7.59E-3 - 4.47E-2 6 6 
Cellular Movement 7.59E-3 - 4.47E-2 19 19 
Cell Cycle 7.59E-3 - 3.74E-2 7 7 
Nucleic Acid Metabolism 7.59E-3 - 3.74E-2 2 2 
DNA Replication, Recombination, and Repair 7.59E-3 - 3.00E-2 4 4 
Metabolic Disease 7.59E-3 - 3.00E-2 4 4 
Cardiovascular Disease 6.18E-3 - 4.47E-2 8 8 
Tissue Development 5.89E-4 - 4.90E-2 22 22 
Skeletal and Muscular System Development and 
Function 5.89E-4 - 4.47E-2 10 10 
Cell Death 4.89E-3 - 4.76E-2 11 11 
Embryonic Development 4.89E-3 - 4.47E-2 4 4 
Cell-To-Cell Signaling and Interaction 4.61E-3 - 4.47E-2 19 19 
Cellular Assembly and Organization 3.58E-3 - 4.47E-2 21 21 
Skeletal and Muscular Disorders 3.58E-3 - 4.47E-2 11 11 
Nutritional Disease 3.00E-2 - 3.74E-2 1 1 
Protein Trafficking 2.26E-2 - 3.00E-2 2 2 
Organismal Development 1.58E-3 - 4.57E-2 15 15 
Vitamin and Mineral Metabolism 1.51E-2 - 4.57E-2 4 4 
Cell Signaling 1.51E-2 - 4.57E-2 19 19 
Post-Translational Modification 1.51E-2 - 3.74E-2 4 4 
Cellular Function and Maintenance 1.51E-2 - 2.26E-2 5 5 
Gene Expression 1.21E-3 - 4.91E-2 27 27 
Lipid Metabolism 1.17E-3 - 4.47E-2 6 6 
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Table 7: Gene ontology analysis of the genes affected in WTPCIR vs KOPCIR comparison 
 
 
Relevant Functions P Value 
No of 
Molecules 
Cellular Compromise 9.02E-3 - 4.43E-2 7 7 
Lipid Metabolism 9.02E-3 - 4.43E-2 6 6 
Organismal Injury and Abnormalities 9.02E-3 - 4.43E-2 6 6 
Cardiovascular Disease 9.02E-3 - 4.43E-2 4 4 
Organismal Development 9.02E-3 - 4.43E-2 4 4 
Carbohydrate Metabolism 9.02E-3 - 4.43E-2 3 3 
Endocrine System Disorders 9.02E-3 - 4.43E-2 3 3 
Small Molecule Biochemistry 9.02E-3 - 4.43E-2 23 23 
Respiratory System Development and Function 9.02E-3 - 4.43E-2 2 2 
Molecular Transport 9.02E-3 - 4.43E-2 12 12 
Skeletal and Muscular System Development and Function 9.02E-3 - 4.43E-2 11 11 
Skeletal and Muscular Disorders 9.02E-3 - 4.38E-2 9 9 
Tissue Development 9.02E-3 - 4.38E-2 12 12 
Organ Development 9.02E-3 - 3.56E-2 6 6 
DNA Replication, Recombination, and Repair 9.02E-3 - 3.56E-2 5 5 
Cardiovascular System Development and Function 9.02E-3 - 2.68E-2 4 4 
Cell Signaling 8.21E-3 - 4.43E-2 5 5 
Cellular Assembly and Organization 7.08E-6 - 4.43E-2 17 17 
Embryonic Development 6.85E-3 - 4.43E-2 9 9 
Cell Death 6.85E-3 - 4.43E-2 8 8 
Cellular Growth and Proliferation 4.49E-4 - 4.43E-2 15 15 
Cell-To-Cell Signaling and Interaction 4.49E-4 - 4.43E-2 13 13 
Organismal Survival 3.02E-2 - 4.11E-2 15 15 
Vitamin and Mineral Metabolism 2.68E-2 - 4.43E-2 2 2 
Amino Acid Metabolism 2.44E-2 - 4.43E-2 9 9 
Post-Translational Modification 2.44E-2 - 4.43E-2 8 8 
Protein Trafficking 2.03E-2 - 2.03E-2 5 5 
Cellular Function and Maintenance 1.80E-2 - 4.43E-2 6 6 
Tissue Morphology 1.65E-3 - 4.43E-2 16 16 
Gene Expression 1.18E-3 - 4.43E-2 10 10 
 
 










